Filtros de búsqueda

Lista de obras de Sawa Ito

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study

artículo científico publicado en 2015

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.

artículo científico publicado en 2014

Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo

artículo científico publicado en 2015

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation

artículo científico publicado en 2015

Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

artículo científico publicado en 2017

Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes

artículo científico publicado en 2018

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

artículo científico publicado en 2014

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2015

Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors.

artículo científico publicado en 2013

Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation

artículo científico publicado en 2017

Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

artículo científico publicado en 2012

Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.

artículo científico publicado en 2016

Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy

artículo científico publicado en 2017

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

scientific article published on 04 April 2016

Gauchers disease--a reappraisal of hematopoietic stem cell transplantation.

artículo científico publicado en 2013

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

artículo científico publicado en 2017

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system

artículo científico publicado en 2016

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells

artículo científico publicado en 2014

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

artículo científico publicado en 2013

Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.

artículo científico publicado en 2016

Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation

artículo científico publicado en 2015

Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib

artículo científico publicado en 2014

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

scientific article published on 01 September 2019

Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study

scientific article published on 13 August 2018

Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

artículo científico publicado en 2015

Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable?

artículo científico publicado en 2014

Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors

artículo científico publicado en 2013

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study

artículo científico publicado en 2017

ST2: the biomarker at the heart of GVHD severity

artículo científico publicado en 2015

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection.

artículo científico publicado en 2017

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

artículo científico publicado en 2014

The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century

artículo científico publicado en 2015

Timing and intensity of exposure to interferon-γ critically determines the function of monocyte-derived dendritic cells.

artículo científico publicado en 2014

Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.

artículo científico publicado en 2016

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

artículo científico publicado en 2014

Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

artículo científico publicado en 2014